New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 22, 2013
08:55 EDTCTIC, CTIC, CTICCell Therapeutics to host analyst and investor meeting
Analyst and Investor Meeting to be held in New York on January 23 at 9 am. Webcast Link
News For CTIC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 2, 2015
17:19 EDTCTICBiotechnology Value Fund reports 5.2% passive stake in CTI BioPharma
October 1, 2015
05:31 EDTCTICCTI BioPharma, Fred Hutchinson Cancer Research Center report research fellowship
Subscribe for More Information
September 24, 2015
16:35 EDTCTICCTI BioPharma announces $15.7M registered direct offering
Subscribe for More Information
September 23, 2015
09:08 EDTCTICCTI BioPharma to submmit NDA for pacrtinib in Q4
CTI BioPharma announced its plan to submit a new drug application to the FDA following a productive pre-NDA meeting for pacritinib, an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1 and CSF1R. The company expects to submit the NDA in Q4 and to request accelerated approval for the treatment of patients with intermediate and high-risk myelofibrosis with low platelet counts of less than 50,000 per microliter. Submission of an NDA after a single Phase 3 trial under accelerated approval, instead of waiting to complete two Phase 3 trials, could potentially reduce time to market by up to 14 months.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use